Merck & Co Inc (NYSE: MRK): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

MRK belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – General industry. The current market capitalization of Merck & Co Inc is $300.25B. A total of 8.87 million shares were traded on the day, compared to an average of 9.58M shares.

In the most recent transaction, Merck & Co., Inc. bought 21,397,205 shares of MRK for 23.00 per share on Mar 11 ’24. After the transaction, the 10% Owner now owns 1,000 company shares. In a previous transaction on Feb 14 ’24, Litchfield Caroline sold 38,291 shares at 125.50 per share. MRK shares that EVP & CFO owns now total 50,908.

Among the insiders who sold shares, Davis Robert M disposed of 150,000 shares on Feb 13 ’24 at a per-share price of $125.85. This resulted in the Chairman, CEO & President holding 348,327 shares of MRK after the transaction. In another insider transaction, Davis Robert M sold 85,021 shares at $125.40 per share on Feb 14 ’24. Company shares held by the Chairman, CEO & President now total 348,327.

Dividend

Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Merck & Co Inc pays an annual dividend of $3.04, resulting in a dividend yield of 2.57%, and it has a price to earnings (P/E) ratio of 21.95. MRK’s most recent ex-dividend date was 9/16/2024 when it declared a $0.77 quarterly dividend that was paid in cash on 10/7/2024. Previously, the company paid the dividend on 7/8/2024 with an ex-dividend date of 6/17/2024. The MRK stock dividend was $0.77 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MRK has a high of $134.63 and a low of $99.14.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MRK’s latest balance sheet shows that the firm has $8.10B in Cash & Short Term Investments as of fiscal 2021. There were $33.10B in debt and $23.87B in liabilities at the time. Its Book Value Per Share was $17.19, while its Total Shareholder’s Equity was $38.26B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRK is Buy with a score of 4.84.

Most Popular

Related Posts